Immunotherapy Grants & Funding


Immunotherapy Grants & Funding - Research at Peter Mac

Current Grants and Funding
Susan G. Komen Breast Cancer Foundation Grant: ‘Combining vaccines and adoptive T cell transfer for breast cancer immunotherapy’, 2007–10.

Bob Parker Memorial Foundation Grant: $100,000 pa, ‘Developing improved immunotherapies for kidney cancer’, 2008–10.

National Breast Cancer Foundation (NBCF) and NHMRC Career Development Award: $85,000 pa, ‘The development of effective immunotherapies for cancer’, 2004–08.

NHMRC Career Development Award: $85,500 pa, ‘Preclinical characterization of gene-engineered T cells for immunotherapy of cancer’, 2004–08.

NHMRC Project Grant: $92,250 pa, ‘Generating tumour-specific dendritic cells for cancer therapy, 2007–09.

Cancer Council of Victoria Grant in Aid: $70,000 pa, ’Immunotherapy of Lewis Y+ malignancy using genetically engineered T cells’ 2007–09.

NHMRC Career Development Award: $102,000 p.a., Darcy PK. Development of cancer immunotherapy using gene-engineered T cells in a self-antigen mouse model 2009-12

NHMRC Senior Research Fellowship: $112,000 pa, Kershaw, M, 2009-2013



Printer friendly page

Links



Grants & Funding >
Publications & Patents >
Achievements, Awards & Prizes >
Research Images >

Contact Details
+61 (0)3 9656 1238
michael.kershaw@petermac.org
phil.darcy@petermac.org

Research Personnel
Group Leader
Associate Professor Michael Kershaw

Group Leader
Dr Phillip Darcy

Research Officers
Dr Linda Berry
Jenny Westwood


PhD Students
Hollie Pegram
Sally Amos


Research Assistant
Connie Duong

Laboratory Manager
Jason Brady